Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program?

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal360 enrolled

Overview

The present study aims to assess the prevalence and impact of comorbid psychiatric disorders among patients with chronic obstructive pulmonary disease (COPD) undergoing pulmonary rehabilitation (PR), in order to determine the effects of psychiatric comorbidity on exercise tolerance and physical activity post-PR and HRQoL, as well as to determine the processes by which these psychiatric disorders may impact on these patient behaviours.

Study Type

OBSERVATIONAL

Enrollment

360

Conditions

Chronic Obstructive Pulmonary Disease

Eligibility

Sex: ALLMin age: 40 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients over the age of 40 will be eligible if 2. they are diagnosed with moderate-severe COPD, 3. currently participate to a PR program, and 4. agree to participate. Exclusion Criteria: They will be excluded if: 1. they have any comorbidity that is more important (i.e., more likely to cause morbidity or mortality) than COPD (e.g., active cancer), 2. they have contraindications to exercise (though they will not likely be referred to PR), 3. they have participated in a PR program in the past year, 4. and if they are unable to provide informed consent due to language difficulties or cognitive impairment.

Locations (5)

Jewish Rehabilitation Hospital

Laval, Quebec, Canada

Hopital Charles-Lemoyne

Longueuil, Quebec, Canada

Hopital du Sacre-Coeur de Montreal

Montreal, Quebec, Canada

Centre hospitalier de l'Université de Montréal (CHUM)

Montreal, Quebec, Canada

Outcomes

Primary Outcomes

The change in exercise tolerance at 1-year post-PR

Exercise tolerance will be measured with the 6-minute walking test (6MWT).

Time frame: Participants will be evaluated at 3 time points: (1) post-PR; (2) at 6-mo; (3) at 12-mo follow-up.

Secondary Outcomes

The change in health-related quality of life (HRQoL) at 1-year post-PR

HRQoL will be measured with the 12-Item Short Form Survey and the COPD Assessment Test

Time frame: Participants will be evaluated at 3 time points: (1) post-PR; (2) at 6-mo; (3) at 12-mo follow-up.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.